After a review of over two years, on January 13, 2022, the Commission prohibited Hyundai Heavy Industries Holdings’ (“HHIH”) acquisition of Daewoo Shipbuilding & Marine Engineering (“Daewoo”).[1] This is only the tenth prohibition decision in ten years, and the first since 2019.[2]

In the 2021 edition of this memo, we wrote that antitrust in 2020 received more political and media attention than at any recent time. 2021 beat that standard in multiple ways, and 2022 looks to continue that trend. In addition to continuing the major tech cases brought under the Trump administration, 2021 saw unprecedented levels of legislative activity in antitrust (both federal and state), competition policy taking a leading position across federal agencies and startling new approaches at the Federal Trade Commission (FTC) in particular – new approaches that, while they haven’t yet produced a wave of new enforcement actions, have required changes in thinking about and approaching antitrust issues. We expect these trends to accelerate in 2022.

On January 12, 2022, former European Central Bank official Benoît Coeuré was appointed President of the French Competition Authority (“FCA”) following his hearing by both houses of the French Parliament.[1] He was unanimously appointed by members of the Commission for Economic Affairs of the Assemblée Nationale, while the Commission for Economic Affairs of the Sénat displayed a more balanced distribution of votes (only 12 in favor out of 22 votes cast).

On January 5, 2022, the Paris Court of Appeals annulled a €2 million damages award that the Paris Commercial Court ordered feminine hygiene products company Vania to pay Carrefour[1] as a result of its participation in a cartel in the body care sector, which resulted in maintaining artificially high prices between 2003 and 2006, and for which Vania was fined €45.03 million by the French Competition Authority (“FCA”) in 2014.

On January 5, 2022, France’s top civil court ruled that the question of jurisdiction in the case opposing pharmaceutical company Roche and the French Competition Authority (“FCA”) in respect of the communication campaign led by the FCA in the Avastin/Lucentis case was particularly complex, and decided to refer it to the Tribunal des conflits to be settled.

On January 4, 2022, the Cour de cassation confirmed the rulings of the president of the Court of Appeals validating dawn raids carried out in May 2017 by the French Competition Authority (“FCA”) in the rendering sector.[1]